Credit: Boehringer Ingelheim
January 12, 2024 06:48 AM ESTUpdated 07:52 AM
Manufacturing

Boehringer al­lo­cates €120M to boost pro­duc­tion of Jar­diance in Greek plant

Anna Brown

News Reporter

Boehringer In­gel­heim is un­der­go­ing a €120 mil­lion ex­pan­sion of its fa­cil­i­ty in Ko­ropi, Greece, to boost pro­duc­tion of its block­buster drug Jar­diance, among oth­er com­mer­cial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times